Loading...
XNAS
OPRX
Market cap263mUSD
Dec 05, Last price  
14.24USD
1D
-2.80%
1Q
-24.34%
Jan 2017
486.01%
IPO
251.60%
Name

OPTIMIZERx Corp

Chart & Performance

D1W1MN
XNAS:OPRX chart
P/E
P/S
2.86
EPS
Div Yield, %
Shrs. gr., 5y
6.44%
Rev. gr., 5y
30.23%
Revenues
92m
+28.81%
100,31883,68626,72371,0651,111,5202,048,6994,957,0166,502,9627,220,6787,751,46212,127,42221,206,36324,598,27443,313,32361,292,59862,450,15671,521,50692,127,000
Net income
-20m
L+14.48%
-361,466-4,248,853-4,555,689-2,009,024-2,120,762-363,976215,847-1,025,393-595,140-1,539,203-2,104,029226,344-3,142,576-2,383,740273,929-10,586,142-17,565,866-20,110,000
CFO
5m
P
-303,633-919,402-1,769,562-1,311,413-521,509-624,0331,132,628-56,350515,110-465,965-1,479,831792,555-1,660,796-6,310,386726,03910,654,078-7,239,1534,889,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.
IPO date
May 18, 2005
Employees
109
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT